These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1175 related articles for article (PubMed ID: 25548312)

  • 21. Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Savarese G; Sartipy U; Friberg L; Dahlström U; Lund LH
    Heart; 2018 Jul; 104(13):1093-1100. PubMed ID: 29371374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the Appropriateness of Oral Anticoagulation for Atrial Fibrillation in Advanced Frailty: Use of Stroke and Bleeding Risk-Prediction Models.
    O'Caoimh R; Igras E; Ramesh A; Power B; O'Connor K; Liston R
    J Frailty Aging; 2017; 6(1):46-52. PubMed ID: 28244558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Atrial fibrillation and stroke].
    Aamodt AH; Sandset PM; Atar D; Tveit A; Russell D
    Tidsskr Nor Laegeforen; 2013 Aug; 133(14):1453-7. PubMed ID: 23929293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk.
    Lubitz SA; Khurshid S; Weng LC; Doros G; Keach JW; Gao Q; Gehi AK; Hsu JC; Reynolds MR; Turakhia MP; Maddox TM
    Am Heart J; 2018 Jun; 200():24-31. PubMed ID: 29898845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores.
    Esteve-Pastor MA; Marín F; Bertomeu-Martinez V; Roldán-Rabadán I; Cequier-Fillat Á; Badimon L; Muñiz-García J; Valdés M; Anguita-Sánchez M;
    Intern Med J; 2016 May; 46(5):583-9. PubMed ID: 26929032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.
    Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK;
    Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation.
    Durham TA; Hassmiller Lich K; Viera AJ; Fine JP; Mukherjee J; Weinberger M; Dusetzina SB
    Am J Cardiol; 2017 Nov; 120(10):1820-1829. PubMed ID: 28867127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stroke prevention in atrial fibrillation and 'real world' adherence to guidelines in the Balkan Region: The BALKAN-AF Survey.
    Potpara TS; Dan GA; Trendafilova E; Goda A; Kusljugic Z; Manola S; Music L; Musetescu R; Badila E; Mitic G; Paparisto V; Dimitrova ES; Polovina MM; Petranov SL; Djergo H; Loncar D; Bijedic A; Brusich S; Lip GY;
    Sci Rep; 2016 Feb; 6():20432. PubMed ID: 26869284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
    Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort.
    Gundlund A; Xian Y; Peterson ED; Butt JH; Gadsbøll K; Bjerring Olesen J; Køber L; Torp-Pedersen C; Gislason GH; Loldrup Fosbøl E
    JAMA Netw Open; 2018 May; 1(1):e180171. PubMed ID: 30646049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
    Wilke T; Groth A; Mueller S; Pfannkuche M; Verheyen F; Linder R; Maywald U; Kohlmann T; Feng YS; Breithardt G; Bauersachs R
    Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
    McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
    Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?
    Fauchier L; Clementy N; Bisson A; Ivanes F; Angoulvant D; Babuty D; Lip GY
    Stroke; 2016 Jul; 47(7):1831-6. PubMed ID: 27231269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of non-traffic-, non-cancer-related bone fractures: A population-based cohort study.
    Lai HC; Chien WC; Chung CH; Lee WL; Wu TJ; Wang KY; Liu CN; Liu TJ
    Eur J Intern Med; 2015 Dec; 26(10):798-806. PubMed ID: 26493861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
    Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
    J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk: Insights From the NCDR PINNACLE Registry.
    Hsu JC; Maddox TM; Kennedy KF; Katz DF; Marzec LN; Lubitz SA; Gehi AK; Turakhia MP; Marcus GM
    JAMA Cardiol; 2016 Apr; 1(1):55-62. PubMed ID: 27437655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?
    Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
    Heart Rhythm; 2016 Jan; 13(1):46-53. PubMed ID: 26277496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.